Viridian Therapeutics Inc (VRDN): Eigentümerstruktur
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 36,2 US Dollar | 14 | 3 | 0 | 0 | 0 |
| #Shares | Short [%] | Short Ratio |
| 113.292.269 | 16,47 | 8,44 |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name Viridian Therapeutics Inc
Mitarbeiter 252
Handelsplatz NASDAQ
Ticker Symbol VRDN
IPO Datum 2014-06-18
Adresse 221 Crescent Street, Waltham, MA, United States, 02453
Webseite https://www.viridiantherapeutics.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Mr. Stephen F. Mahoney J.D., MBA | CEO, President & Director |
| 2 | Mr. Seth Harmon | Chief Financial Officer |
| 3 | Mr. Thomas W. Beetham J.D., MBA | Chief Operating Officer |
| 4 | Ms. Jennifer Tousignant J.D. | Chief Legal Officer & Corporate Secretary |
| 5 | Dr. Radhika Tripuraneni M.D., M.P.H. | Chief Medical Officer |
| 6 | Dr. Eric N. Olson Ph.D. | Co-Founder & Chairman of Scientific Advisory Board |
| 7 | Dr. Michael R. Bristow M.D., Ph.D. | Co-Founder & Member of the Scientific Advisory Board |
| 8 | Dr. Marvin H. Caruthers Ph.D. | Co-Founder & Scientific Advisory Board Member |
| 9 | Mr. Vahe Bedian Ph.D. | Co-Founder & Scientific Advisor |
| 10 | Ms. Melissa Manno | Chief Human Resources Officer |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | FMR Inc | 14,66% | 0,40 Mrd. USD |
| 2 | BlackRock Inc | 7,55% | 0,21 Mrd. USD |
| 3 | Bellevue Group AG | 5,94% | 0,16 Mrd. USD |
| 4 | Paradigm Biocapital Advisors LP | 5,93% | 0,16 Mrd. USD |
| 5 | Kynam Capital Management, LP | 5,70% | 0,16 Mrd. USD |
| 6 | State Street Corp | 5,41% | 0,15 Mrd. USD |
| 7 | T. Rowe Price Associates, Inc. | 5,07% | 0,14 Mrd. USD |
| 8 | Fairmount Funds Management LLC | 4,49% | 0,12 Mrd. USD |
| 9 | Vanguard Capital Management, LLC | 4,04% | 0,11 Mrd. USD |
| 10 | Deep Track Capital, LP | 3,17% | 0,09 Mrd. USD |
| 11 | VR Adviser, LLC | 2,88% | 0,08 Mrd. USD |
| 12 | Wellington Management Company LLP | 2,76% | 0,08 Mrd. USD |
| 13 | Vanguard Portfolio Management, LLC | 2,43% | 0,07 Mrd. USD |
| 14 | Geode Capital Management, LLC | 2,21% | 0,06 Mrd. USD |
| 15 | venBio Select Advisor LLC | 2,21% | 0,06 Mrd. USD |
| 16 | Baker Bros Advisors LP | 2,10% | 0,06 Mrd. USD |
| 17 | Point72 Asset Management, L.P. | 2,07% | 0,06 Mrd. USD |
| 18 | Caligan Partners LP | 1,94% | 0,05 Mrd. USD |
| 19 | Novo A/S | 1,88% | 0,05 Mrd. USD |
| 20 | TANG CAPITAL MANAGEMENT LLC | 1,58% | 0,04 Mrd. USD |